Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


France Latest Country To Introduce Digital Medtech Reimbursement Fast-Track

Executive Summary

France has introduced a fast-track market access pathway for certain digital health products, adding to similar schemes in neighboring EU countries Germany and Belgium. But how does the new reimbursement program work, and which products are eligible for coverage?

You may also be interested in...

UK’s NHS Launches AI Regulation Service Specifically For Medtech Firms

The regulatory landscape for digital and AI-based products can be tough for companies and users alike to navigate. Four UK organizations have partnered up to create a service that aims to demystify complex regulatory rules around AI and digital medtech.

French Medtech Reimbursement - How Added Value And Clinical Benefit Sway Decisions

In France, many medical devices require value assessments prior to securing market access, a process that manufacturers may find complex. Hubert Galmiche, head of medical device assessment at the French National Authority for Health (HAS) explains what the outcomes of these appraisals mean for companies.

Digital Health Technologies: Where The Shift Is Needed In The EU To Increase Uptake

The market for the reimbursement of digital health technologies is being held back because of the current fragmentation in reimbursement and funding. MedTech Europe is calling for change.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts